961 results match your criteria Buruli Ulcer


Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.

mSphere 2019 Feb 6;4(1). Epub 2019 Feb 6.

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Buruli ulcer is a neglected tropical disease of skin and subcutaneous tissue caused by infection with the pathogen Many critical issues for disease control, such as understanding the mode of transmission and identifying source reservoirs of , are still largely unknown. Here, we used genomics to reconstruct in detail the evolutionary trajectory and dynamics of populations at a central African scale and at smaller geographical village scales. Whole-genome sequencing (WGS) data were analyzed from 179 strains isolated from all Buruli ulcer foci in the Democratic Republic of the Congo, The Republic of Congo, and Angola that have ever yielded positive cultures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/mSphere.00472-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365612PMC
February 2019

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay.

PLoS Negl Trop Dis 2019 Feb 1;13(2):e0007155. Epub 2019 Feb 1.

Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Background: Access to an accurate diagnostic test for Buruli ulcer (BU) is a research priority according to the World Health Organization. Nucleic acid amplification of insertion sequence IS2404 by polymerase chain reaction (PCR) is the most sensitive and specific method to detect Mycobacterium ulcerans (M. ulcerans), the causative agent of BU. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0007155DOI Listing
February 2019
1 Read

The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.

Nat Commun 2019 Jan 31;10(1):524. Epub 2019 Jan 31.

State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, 510530, China.

Buruli ulcer (BU) is an emerging infectious disease that causes disfiguring skin ulcers. The causative agent, Mycobacterium ulcerans, secretes toxin called mycolactone that triggers inflammation and immunopathology. Existing treatments are lengthy and consist of drugs developed for tuberculosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-08464-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355801PMC
January 2019
1 Read

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.

PLoS Negl Trop Dis 2019 Jan 28;13(1):e0007126. Epub 2019 Jan 28.

Research & Development Agency of Aragon (ARAID) Foundation, Zaragoza, Spain.

The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans. Beta-lactams tested were effective alone and displayed a strong synergistic profile in combination with antibiotics currently used to treat BU, i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0007126DOI Listing
January 2019

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.

BMC Infect Dis 2019 Jan 10;19(1):41. Epub 2019 Jan 10.

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

Background: Nigeria accounts for a significant proportion of the global drug-resistant tuberculosis (DR-TB) burden, a large proportion of which goes untreated. Different models for managing DR-TB treatment with varying levels of hospitalization are in use across Nigeria, however costing evidence is required to guide the scale up of DR-TB care. We aimed to estimate and compare the costs of different DR-TB treatment and care models in Nigeria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-018-3636-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327521PMC
January 2019
3 Reads

Comparison of Mycobacterium ulcerans (Buruli ulcer) and Leptospira sp. (Leptospirosis) dynamics in urban and rural settings.

PLoS Negl Trop Dis 2019 01 7;13(1):e0007074. Epub 2019 Jan 7.

Equipe EA 3593, Ecosystèmes amazoniens et pathologie tropicale, Université de la Guyane, Cayenne, Guyane française.

Background: Zoonotic pathogens respond to changes in host range and/or pathogen, vector and host ecology. Environmental changes (biodiversity, habitat changes, variability in climate), even at a local level, lead to variability in environmental pathogen dynamics and can facilitate their transmission from natural reservoirs to new susceptible hosts. Whilst the environmental dynamics of aquatic bacteria are directly linked to seasonal changes of their habitat they also rely on the ecological processes underpining their transmission. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0007074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336349PMC
January 2019
2 Reads

Targeting the Mycobacterium ulcerans cytochrome bc:aa for the treatment of Buruli ulcer.

Nat Commun 2018 12 18;9(1):5370. Epub 2018 Dec 18.

Lee Kong Chian School of Medicine, Nanyang Technological University, Experimental Medicine Building, Singapore, 636921, Singapore.

Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are limited to antibiotics with severe side effects. Here, we show that M. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-07804-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299076PMC
December 2018
2 Reads

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.

Antimicrob Agents Chemother 2018 Dec 17. Epub 2018 Dec 17.

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Rifampin (RIF) plus clarithromycin (CLR) for 8 weeks is now the standard of care for Buruli ulcer (BU) treatment, but CLR may not be an ideal companion for rifamycins due to bidirectional drug-drug interactions. The oxazolidinone linezolid (LZD) was previously shown to be active against infection in mice but has dose- and duration-dependent toxicity in humans. Sutezolid (SZD) and tedizolid (TZD) may be safer than LZD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02171-18DOI Listing
December 2018

Treatment for Buruli ulcer: the long and winding road to antimicrobials-first.

Cochrane Database Syst Rev 2018 12;12:ED000128

University of Groningen, University Medical Center Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.ED000128DOI Listing
December 2018

Buruli ulcers in a Spanish aid worker after a stay in Peru.

Int J Infect Dis 2019 Jan 25;78:99-102. Epub 2018 Oct 25.

Infectious Diseases Service, Hospital Ramón y Cajal, Madrid, Spain.

Buruli ulcer (BU) is a chronic and destructive infection of the skin and soft tissues caused by Mycobacterium ulcerans. Recently, population flows have triggered the appearance of several sporadic cases of BU in non-endemic countries. This represents a significant diagnostic challenge for clinicians and microbiologists. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2018.10.012DOI Listing
January 2019
2 Reads

Buruli Ulcer: a Review of the Current Knowledge.

Curr Trop Med Rep 2018 28;5(4):247-256. Epub 2018 Sep 28.

10Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Purpose Of The Review: Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by , one of the skin-related neglected tropical diseases (skin NTDs). This article aims to review the current knowledge of this disease and challenges ahead.

Recent Findings: Around 60,000 cases of BU have been reported from over 33 countries between 2002 and 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40475-018-0166-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223704PMC
September 2018
28 Reads

High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.

Antimicrob Agents Chemother 2019 Feb 29;63(2). Epub 2019 Jan 29.

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Buruli ulcer (BU), caused by , is a neglected tropical skin and soft tissue infection that is associated with disability and social stigma. The mainstay of BU treatment is an 8-week course of rifampin (RIF) at 10 mg/kg of body weight and 150 mg/kg streptomycin (STR). Recently, the injectable STR has been shown to be replaceable with oral clarithromycin (CLR) for smaller lesions for the last 4 weeks of treatment. Read More

View Article

Download full-text PDF

Source
http://aac.asm.org/lookup/doi/10.1128/AAC.01478-18
Publisher Site
http://dx.doi.org/10.1128/AAC.01478-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355596PMC
February 2019
7 Reads

Integrated Management of Skin NTDs-Lessons Learned from Existing Practice and Field Research.

Authors:
Rie R Yotsu

Trop Med Infect Dis 2018 Nov 14;3(4). Epub 2018 Nov 14.

School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki 852-8102, Japan.

Integration of neglected tropical diseases (NTDs) into the public health agenda has been a priority in global health for the last decade. Because a number of these diseases share not only the geographical distribution, but also a common feature which is skin involvement, bringing together a sub-group of 'skin NTDs' is one way forward to promote further integration among NTDs. With these diseases, which include leprosy, Buruli ulcer, yaws, mycetoma, lymphatic filariasis, and leishmaniasis, patients may be left with life-long deformities and disabilities when diagnosis and treatment are delayed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/tropicalmed3040120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306929PMC
November 2018
1 Read

Cutaneous Mycobacterial Infections.

Clin Microbiol Rev 2018 01 14;32(1). Epub 2018 Nov 14.

Servicio de Dermatología y Departamento de Micología, Hospital General de México, Mexico City, Mexico.

Humans encounter mycobacterial species due to their ubiquity in different environmental niches. In many individuals, pathogenic mycobacterial species may breach our first-line barrier defenses of the innate immune system and modulate the activation of phagocytes to cause disease of the respiratory tract or the skin and soft tissues, sometimes resulting in disseminated infection. Cutaneous mycobacterial infections may cause a wide range of clinical manifestations, which are divided into four main disease categories: (i) cutaneous manifestations of infection, (ii) Buruli ulcer caused by and other related slowly growing mycobacteria, (iii) leprosy caused by and , and (iv) cutaneous infections caused by rapidly growing mycobacteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/CMR.00069-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302357PMC
January 2018
4 Reads

PCR detection of Mycobacterium ulcerans-significance for clinical practice and epidemiology.

Expert Rev Mol Diagn 2018 Nov 1:1-12. Epub 2018 Nov 1.

a Division of Infectious Diseases and Tropical Medicine , University Hospital, Ludwigs-Maximilians-University , Munich , Germany.

Introduction: Buruli ulcer (BU) is a neglected disease which has been reported from mostly impoverished, remote rural areas from 35 countries worldwide. BU affects skin, subcutaneous tissue, and bones, and may cause massive tissue destruction and life-long disabilities if not diagnosed and treated early. Without laboratory confirmation diagnostic and treatment errors may occur. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2018.1543592DOI Listing
November 2018
2 Reads

Buruli ulcer in southern Côte D'ivoire: dynamic schemes of perception and interpretation of modes of transmission.

J Biosoc Sci 2018 Oct 31:1-14. Epub 2018 Oct 31.

2Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS),Abidjan,Côte d'Ivoire.

Buruli ulcer (BU) belongs to the group of neglected tropical diseases and constitutes a public health problem in many rural communities in Côte d'Ivoire. The transmission patterns of this skin infection are poorly defined, hence the current study aimed to contribute to the understanding, perceptions and interpretations of its mode of transmission using a socio-environmental approach. Social and environmental risk factors that may expose people to infection, and the dynamics of local transfer of knowledge and practices related to BU, were assessed in two endemic locations in southern Côte d'Ivoire, i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0021932018000317DOI Listing
October 2018
3 Reads

Epidemiology of Buruli Ulcer Infections, Victoria, Australia, 2011-2016.

Emerg Infect Dis 2018 11;24(11):1988-1997

Buruli ulcer (BU) is a destructive soft-tissue infection caused by the environmental pathogen Mycobacterium ulcerans. In response to rising BU notifications in the state of Victoria, Australia, we reviewed all cases that occurred during 2011-2016 to precisely map the time and likely place of M. ulcerans acquisition. Read More

View Article

Download full-text PDF

Source
http://wwwnc.cdc.gov/eid/article/24/11/17-1593_article.htm
Publisher Site
http://dx.doi.org/10.3201/eid2411.171593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199991PMC
November 2018
9 Reads

Genetic characterization of complex isolates circulating in Abuja, Nigeria.

Infect Drug Resist 2018 1;11:1617-1625. Epub 2018 Oct 1.

Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain,

Objective: Nigeria ranks fourth among the high tuberculosis (TB) burden countries. This study describes the prevalence of drug resistance and the genetic diversity of in Abuja's Federal Capital Territory.

Materials And Methods: Two hundred and seventy-eight consecutive sputum samples were collected from adults with presumptive TB during 2013-2014. Read More

View Article

Download full-text PDF

Source
https://www.dovepress.com/genetic-characterization-of-mycoba
Publisher Site
http://dx.doi.org/10.2147/IDR.S166986DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171509PMC
October 2018
14 Reads

Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.

MBio 2018 10 9;9(5). Epub 2018 Oct 9.

Global Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection with We report here on our work with AX-35, an arylvinylpiperazine amide, and four related analogs, which are potent antitubercular agents All five compounds showed good activity against and in infected THP-1 macrophages, while displaying only mild cytotoxicity. Isolation and characterization of -resistant mutants to the arylvinylpiperazine amide derivative AX-35 revealed mutations in the gene encoding a subunit of cytochrome oxidase, one of two terminal oxidases of the electron transport chain. Cross-resistance studies, allelic exchange, transcriptomic analyses, and bioenergetic flux assays provided conclusive evidence that the cytochrome is the target of AX-35, although the compound appears to interact differently with the quinol binding pocket compared to previous QcrB inhibitors. Read More

View Article

Download full-text PDF

Source
http://mbio.asm.org/lookup/doi/10.1128/mBio.01276-18
Publisher Site
http://dx.doi.org/10.1128/mBio.01276-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178619PMC
October 2018
5 Reads

The changing epidemiology worldwide of Mycobacterium ulcerans.

Epidemiol Infect 2018 Oct 8:1-8. Epub 2018 Oct 8.

Geelong Centre for Emerging Infectious Diseases,Geelong,Australia.

Mycobacterium ulcerans is recognised as the third most common mycobacterial infection worldwide. It causes necrotising infections of skin and soft tissue and is classified as a neglected tropical disease by the World Health Organization (WHO). However, despite extensive research, the environmental reservoir of the organism and mode of transmission of the infection to humans remain unknown. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S095026881
Publisher Site
http://dx.doi.org/10.1017/S0950268818002662DOI Listing
October 2018
9 Reads

Potential Animal Reservoir of : A Systematic Review.

Trop Med Infect Dis 2018 May 30;3(2). Epub 2018 May 30.

Australian Institute of Tropical Health & Medicine, James Cook University, Smithfield, QLD 4878, Australia.

is the causative agent of Buruli ulcer, also known in Australia as Daintree ulcer or Bairnsdale ulcer. This destructive skin disease is characterized by extensive and painless necrosis of the skin and soft tissue with the formation of large ulcers, commonly on the leg or arm. To date, 33 countries with tropical, subtropical and temperate climates in Africa, the Americas, Asia and the Western Pacific have reported cases of Buruli ulcer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/tropicalmed3020056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073983PMC
May 2018
2 Reads

Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.

ANZ J Surg 2018 Sep 21. Epub 2018 Sep 21.

Department of Plastic Surgery, Barwon Health, Geelong, Victoria, Australia.

With the demonstration of the effectiveness of antibiotic treatment, the management of Mycobacterium ulcerans disease has changed from a predominantly surgically to a predominantly medically treated disease. However, research among Australian patients has revealed that antibiotic treatment alone is associated with prolonged wound healing times, high rates of treatment toxicity, and the potential for significant tissue destruction associated with severe paradoxical reactions. We present the current state of M. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.14829DOI Listing
September 2018
1 Read
1.120 Impact Factor

The association of rainfall and Buruli ulcer in southeastern Australia.

PLoS Negl Trop Dis 2018 09 17;12(9):e0006757. Epub 2018 Sep 17.

University of Melbourne, Department of Medicine, Austin Health, Heidelberg, Victoria, Australia.

Background: Buruli ulcer has been increasing in incidence in southeastern Australia with unclear transmission mechanisms. We aimed to investigate the link between rainfall and case numbers in two endemic areas of the state of Victoria; the Bellarine and Mornington Peninsulas.

Methodology: We created yearly and monthly graphs comparing rainfall with local Buruli ulcer incidence for the period 2004-2016 by endemic region and then considered a range of time lag intervals of 0-24 months to investigate patterns of correlation. Read More

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.pntd.0006757
Publisher Site
http://dx.doi.org/10.1371/journal.pntd.0006757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160213PMC
September 2018
11 Reads

Implementing active community-based surveillance-response system for Buruli ulcer early case detection and management in Ghana.

PLoS Negl Trop Dis 2018 09 12;12(9):e0006776. Epub 2018 Sep 12.

National BU Control Program, Ghana Health Service Korle-Bu, Accra, Ghana.

Background: Buruli Ulcer (BU) is one of the most neglected debilitating tropical diseases caused by Mycobacterium ulcerans, which causes considerable morbidity and disability. Building on earlier findings that community-based interventions could enhance case detection and reduce treatment dropout and defaulter rates, we established an active surveillance-response system in an endemic sub-district in the Ga West municipality of Ghana to enhance early case detection, diagnosis and treatment to reduce or eliminate severe ulcers and its related disabilities.

Methods: We established surveillance response system, implemented in collaboration with the sub-district disease control officers, selected clinical staff and trained community-based volunteers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152995PMC
September 2018
1 Read

Modelling the spatial distribution of aquatic insects (Order Hemiptera) potentially involved in the transmission of Mycobacterium ulcerans in Africa.

Parasit Vectors 2018 Sep 6;11(1):501. Epub 2018 Sep 6.

Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Background: Biting aquatic insects belonging to the order Hemiptera have been suggested as potential vectors of Mycobacterium ulcerans in endemic areas for Buruli ulcer (BU). If this is the case, these insects would be expected to co-exist with M. ulcerans in the same geographical areas. Read More

View Article

Download full-text PDF

Source
https://parasitesandvectors.biomedcentral.com/articles/10.11
Publisher Site
http://dx.doi.org/10.1186/s13071-018-3066-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127916PMC
September 2018
4 Reads

Challenges associated with the treatment of Buruli ulcer.

J Leukoc Biol 2019 Feb 31;105(2):233-242. Epub 2018 Aug 31.

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Buruli ulcer (BU), caused by Mycobacterium ulcerans (MU), is the third most important mycobacterial diseases after tuberculosis and leprosy in immunocompetent individuals. Although the mode of transmission remains an enigma, disease incidence has been strongly linked to disturbed environment and wetlands. The blunt of the diseases is recorded in West African countries along the Gulf of Guinea, and children 15 years and below account for about 48% of all cases globally. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/JLB.MR0318-128DOI Listing
February 2019
3 Reads

Surgery for Buruli ulcer in the antibiotic era.

Lancet Infect Dis 2018 Sep;18(9):947

Rickmansworth WD3 1HH, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(18)30474-2DOI Listing
September 2018
9 Reads

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Cochrane Database Syst Rev 2018 08 23;8:CD012118. Epub 2018 Aug 23.

Department of Dermatology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan, 162-8655.

Background: Buruli ulcer is a necrotizing cutaneous infection caused by infection with Mycobacterium ulcerans bacteria that occurs mainly in tropical and subtropical regions. The infection progresses from nodules under the skin to deep ulcers, often on the upper and lower limbs or on the face. If left undiagnosed and untreated, it can lead to lifelong disfigurement and disabilities. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD012118.pub2DOI Listing
August 2018
7 Reads

Human genetics of mycobacterial disease.

Mamm Genome 2018 08 16;29(7-8):523-538. Epub 2018 Aug 16.

Program in Infectious Diseases and Immunity in Global Health, Research Institute, McGill University Health Centre, Montreal, QC, Canada.

Mycobacterial diseases are caused by members of the genus Mycobacterium, acid-fast bacteria characterized by the presence of mycolic acids within their cell walls. Claiming almost 2 million lives every year, tuberculosis (TB) is the most common mycobacterial disease and is caused by infection with M. tuberculosis and, in rare cases, by M. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00335-018-9765-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132723PMC
August 2018
7 Reads

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.

PLoS Negl Trop Dis 2018 08 13;12(8):e0006728. Epub 2018 Aug 13.

Department of Medicine, Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland, United States of America.

Trial Registration: ClinicalTrials.gov NCT03474198, NCT01659437. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107292PMC
August 2018
4 Reads

Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region.

PLoS Negl Trop Dis 2018 08 13;12(8):e0006724. Epub 2018 Aug 13.

Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.

We examined recurrent Buruli ulcer cases following treatment and assumed cure in a large cohort of Australian patients living in an endemic area. We report that while the recurrence rate was low (2.81 cases/year/1000 population), it remained similar to the estimated risk of primary infection within the general population of the endemic area (0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006724DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107289PMC
August 2018
1 Read

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection.

PeerJ 2018 31;6:e5294. Epub 2018 Jul 31.

Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Background: Buruli ulcer is a disease of the skin and soft tissues caused by infection with a slow growing pathogen, . A vaccine for this disease is not available but possesses a giant plasmid pMUM001 that harbours the polyketide synthase (PKS) genes encoding a multi-enzyme complex needed for the production of its unique lipid toxin called mycolactone, which is central to the pathogenesis of Buruli ulcer. We have studied the immunogenicity of enzymatic domains in humans with disease, their contacts, as well as non-endemic areas controls. Read More

View Article

Download full-text PDF

Source
https://peerj.com/articles/5294
Publisher Site
http://dx.doi.org/10.7717/peerj.5294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078848PMC
July 2018
8 Reads

Improving clinical and epidemiological predictors of Buruli ulcer.

PLoS Negl Trop Dis 2018 08 6;12(8):e0006713. Epub 2018 Aug 6.

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Background: Buruli ulcer (BU) is a chronic necrotizing infectious skin disease caused by Mycobacterium ulcerans. The treatment with BU-specific antibiotics is initiated after clinical suspicion based on the WHO clinical and epidemiological criteria. This study aimed to estimate the predictive values of these criteria and how they could be improved. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095624PMC
August 2018
12 Reads

Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response.

Med J Aust 2018 Aug;209(3):142

University Hospitals Bristol Education and Research Centre, Bristol, UK.

View Article

Download full-text PDF

Source
August 2018
6 Reads

Understanding perceptions on 'Buruli' in northwestern Uganda: A biosocial investigation.

Authors:
Georgina Pearson

PLoS Negl Trop Dis 2018 07 30;12(7):e0006689. Epub 2018 Jul 30.

Department of International Development, London School of Economics and Political Science, London, United Kingdom.

Background: An understudied disease, little research thus far has explored responses to Buruli ulcer and quests for therapy from biosocial perspective, despite reports that people seek biomedical treatment too late.

Methods And Findings: Taking an inductive approach and drawing on long-term ethnographic fieldwork in 2013-14, this article presents perspectives on this affliction of people living and working along the River Nile in northwest Uganda. Little is known biomedically about its presence, yet 'Buruli', as it is known locally, was and is a significant affliction in this region. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085067PMC

Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.

Biol Cell 2018 Nov 14;110(11):237-248. Epub 2018 Aug 14.

Division of Molecular and Cellular Function, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Infection with Mycobacterium ulcerans results in a necrotising skin disease known as a Buruli ulcer, the pathology of which is directly linked to the bacterial production of the toxin mycolactone. Recent studies have identified the protein translocation machinery of the endoplasmic reticulum (ER) membrane as the primary cellular target of mycolactone, and shown that the toxin binds to the core subunit of the Sec61 complex. Mycolactone binding strongly inhibits the capacity of the Sec61 translocon to transport newly synthesised membrane and secretory proteins into and across the ER membrane. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/boc.201800030DOI Listing
November 2018

Perception and incidence of Buruli ulcer in Ogun State, South West Nigeria: intensive epidemiological survey and public health intervention recommended.

Pan Afr Med J 2018 22;29:166. Epub 2018 Mar 22.

Department of Veterinary Public Health and Preventive Medicine, University Of Ibadan, Ibadan, Oyo state, Nigeria.

Introduction: Buruli ulcer (BU) is a highly ranked neglected tropical disease (NTD) of global health importance with increasing incidence in sub-Saharan Africa yet there is paucity of information on the epidemiology of BU in Nigeria. Incidentally, highly BU endemic Benin Republic shares proximity with Nigeria. This study was carried out to establish presence of BU and ascertain the level of BU perception among rural populace in Ogun State, south-west Nigeria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2018.29.166.10110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057600PMC
August 2018
2 Reads

Domestic animals infected with Mycobacterium ulcerans-Implications for transmission to humans.

PLoS Negl Trop Dis 2018 07 2;12(7):e0006572. Epub 2018 Jul 2.

Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.

Background: The environmental pathogen, Mycobacterium ulcerans (MU) can infect both humans and animals and cause Buruli ulcer (BU) disease. However, its mode(s) of transmission from the colonized environment to human/animal hosts remain unclear. In Australia, MU can infect both wildlife and domestic mammals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044547PMC
July 2018
93 Reads

Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa.

Molecules 2018 Jun 27;23(7). Epub 2018 Jun 27.

Department of Parasitology, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences (CHS), University of Ghana, P. O. Box LG 77, Legon, Accra, Ghana.

Buruli ulcer (BU) is caused by and is predominant in both tropical and subtropical regions. The neglected debilitating disease is characterized by chronic necrotizing skin lesions attributed to a mycolactone, which is a macrolide toxin secreted by . The preferred treatment is surgical excision of the lesions followed by a prolonged combination antibiotic therapy using existing drugs such as rifampicin and streptomycin or clarithromycin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules23071550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100440PMC
June 2018
8 Reads
2.420 Impact Factor

Integrated approach in the control and management of skin neglected tropical diseases in Lalo, Benin.

PLoS Negl Trop Dis 2018 06 25;12(6):e0006584. Epub 2018 Jun 25.

Department of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Background: Neglected Tropical Diseases (NTDs) are a group of several communicable diseases prevalent in the tropical and subtropical areas. The co-endemicity of these diseases, the similarity of the clinical signs, and need to maximize limited financial and human resources have necessitated implementation of integrated approach. Our study aims to share the lessons of this integrated approach in the fight against Buruli ulcer (BU), leprosy and yaws in a rural district in Benin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034899PMC
June 2018
16 Reads
1 Citation

Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016.

PLoS Negl Trop Dis 2018 06 5;12(6):e0006560. Epub 2018 Jun 5.

National Buruli Ulcer Control Program, Ghana Health Service, Accra, Ghana.

Background: Buruli ulcer (BU), a necrotizing skin infection caused by Mycobacterium ulcerans is the third most important mycobacterial disease globally after tuberculosis and leprosy in immune competent individuals. This study reports on the retrospective analyses of microbiologically confirmed Buruli ulcer (BU) cases in seventy-five health facilities in Ghana.

Method/principal Findings: Pathological samples were collected from BU lesions and transported either through courier services or by car directly to the laboratory. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003692PMC
June 2018
20 Reads

Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969-2013: an epidemiological study.

Lancet Planet Health 2017 05 5;1(2):e65-e73. Epub 2017 May 5.

Service de Dermatologie, Cayenne Hospital, Cayenne, French Guiana; Université de Guyane, EA3593 Epidémiologie des Parasitoses Tropicales, Cayenne, French Guiana. Electronic address:

Background: Mycobacterium ulcerans infection is the third most common mycobacterial disease in the world after tuberculosis and leprosy. To date, transmission pathways from its environmental reservoir to humans are still unknown. In South America, French Guiana has the highest reported number of M ulcerans infections across the continent. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2542-5196(17)30009-8DOI Listing
May 2017
2 Reads

Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.

Sci Rep 2018 May 29;8(1):8218. Epub 2018 May 29.

Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU), a WHO-defined neglected tropical disease. All Japanese BU causative isolates have shown distinct differences from the prototype and are categorized as M. ulcerans subspecies shinshuense. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-26425-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974349PMC
May 2018
8 Reads

Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo.

PLoS Negl Trop Dis 2018 05 21;12(5):e0006455. Epub 2018 May 21.

Department for infectious diseases and tropical medicine (DITM), Medical center of the University of Munich (LMU), Munich, Germany.

Background: Buruli Ulcer (BU) is a neglected tropical skin infection caused by Mycobacterium ulcerans. Residence near aquatic areas has been identified as an important source of transmission of M. ulcerans with increased risk of contracting Buruli ulcer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983864PMC
May 2018
8 Reads

Skin disease prevalence study in schoolchildren in rural Côte d'Ivoire: Implications for integration of neglected skin diseases (skin NTDs).

PLoS Negl Trop Dis 2018 05 17;12(5):e0006489. Epub 2018 May 17.

Global Buruli Ulcer Initiative, World Health Organization, Geneva, Switzerland.

Background: Early detection of several skin-related neglected tropical diseases (skin NTDs)-including leprosy, Buruli ulcer, yaws, and scabies- may be achieved through school surveys, but such an approach has seldom been tested systematically on a large scale in endemic countries. Additionally, a better understanding of the spectrum of skin diseases and the at-risk populations to be encountered during such surveys is necessary to facilitate the process.

Methods: We performed a school skin survey for selected NTDs and the spectrum of skin diseases, among primary schoolchildren aged 5 to 15 in Côte d'Ivoire, West Africa. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976208PMC
May 2018
8 Reads

Buruli (Bairnsdale) ulcer in the setting of long-term adalimumab treatment for Crohn disease.

Intern Med J 2018 05;48(5):603-604

School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13788DOI Listing
May 2018
2 Reads

A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans.

Sci Rep 2018 Apr 30;8(1):6778. Epub 2018 Apr 30.

Aix Marseille Université, URMITE, UMR CNRS 7278, IRD 198, INSERM 1095, IHU Méditerranée Infection, Marseille, 13005, France.

Contaminations and fastidiousness of M. ulcerans may have both hamper isolation of strains from environmental sources. We aimed to optimize decontamination and culture of environmental samples to circumvent both limitations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-25278-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928104PMC
April 2018
4 Reads

Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer.

PLoS Negl Trop Dis 2018 04 30;12(4):e0006429. Epub 2018 Apr 30.

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-1163, Paris, France.

Buruli ulcer (BU), the third most frequent mycobacteriosis worldwide, is a neglected tropical disease caused by Mycobacterium ulcerans. We report the clinical description and extensive genetic analysis of a consanguineous family from Benin comprising two cases of unusually severe non-ulcerative BU. The index case was the most severe of over 2,000 BU cases treated at the Centre de Dépistage et de Traitement de la Lèpre et de l'Ulcère de Buruli, Pobe, Benin, since its opening in 2003. Read More

View Article

Download full-text PDF

Source
https://dx.plos.org/10.1371/journal.pntd.0006429
Publisher Site
http://dx.doi.org/10.1371/journal.pntd.0006429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945055PMC
April 2018
19 Reads
1 Citation